For the reduction of atherosclerotic events in patients with atherosclerosis documented by recent stroke, myocardial infarction, or peripheral arterial disease
For patients with a history of recent myocardial infarction (Ml), recent stroke, or established peripheral arterial disease and Acute Coronary Syndrome.
Reduction of atherothrombotic events: Recent MI, Recent Stroke or Peripheral Arterial Disease for patients with myocardial infarction (MI), recent stroke.
Indicated for the reduction of atherothrombotic events in Recent MI, Recent Stroke or Established Peripheral Arterial Disease and Acute Coronary Syndrome,
Reduces the risk of episodes in patients with overt cardiovascular diseases including primary and secondary prevention of heart attack and stroke.